David Meek | CEO |
Ryan Asay | Vice President of Corporate Affairs at Mirati |
Charles Baum | President, Founder and Head of Research and Development |
Dr. James Christensen | Chief Scientific Officer |
Vickie S. Reed | Chief Accounting Officer |
Gena Wang | Barclays |
Umer Raffat | Evercore |
Salveen Richter | Goldman Sachs |
Anupam Rama | JP Morgan |
Gabe Daoud | Cowen |
Michael Schmidt | Guggenheim |
Yigal Nochomovitz | Citi |
Maury Raycroft | Jefferies |
Ben Burnett | Stifel |
Jason Gerberry | Bank of America |
Andrew Burns | SVB Leerink |
Good afternoon, ladies and gentlemen. Welcome to the Mirati Therapeutics Third Quarter 2021 earnings call. My name is Keith (ph) and I'll be your operator for today's call. All lines have been placed on mute to prevent any background noise. After the conclusion of the speaker's prepared remarks, there will be a question-and-answer session.